Use of positron emission tomography for the diagnosis of immune-checkpoint inhibitor| myocarditis.

Autor: Ali A; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: https://twitter.com/@Abdelcards., Lu Y; Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khalaf S; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Iliescu C; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Koutroumpakis E; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yusuf SW; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Siddiqui BA; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Subudhi SK; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Deswal A; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: https://twitter.com/@anita_deswal., Palaskas NL; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: NLPalaskas@mdanderson.org.

Publikováno v: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology [J Nucl Cardiol] 2024 Sep; Vol. 39, pp. 101909. Date of Electronic Publication: 2024 Jul 23.

Elevated IL-6 and Tumor Necrosis Factor-α in Immune Checkpoint Inhibitor Myocarditis.

Autor: Ali A; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1451, Houston, TX 77030, USA., Caldwell R; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1451, Houston, TX 77030, USA., Pina G; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1451, Houston, TX 77030, USA., Beinart N; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1451, Houston, TX 77030, USA., Jensen G; Texas A&M College of Medicine, Center for Genomics and Precision Medicine, Houston, TX 77030, USA., Yusuf SW; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1451, Houston, TX 77030, USA., Koutroumpakis E; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1451, Houston, TX 77030, USA., Hamzeh I; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1451, Houston, TX 77030, USA., Khalaf S; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1451, Houston, TX 77030, USA., Iliescu C; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1451, Houston, TX 77030, USA., Deswal A; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1451, Houston, TX 77030, USA., Palaskas NL; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1451, Houston, TX 77030, USA.

Publikováno v: Diseases (Basel, Switzerland) [Diseases] 2024 May 03; Vol. 12 (5). Date of Electronic Publication: 2024 May 03.

Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights.

Autor: Jain A; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Casanova D; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Padilla AV; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Paniagua Bojorges A; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kotla S; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ko KA; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Samanthapudi VSK; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Chau K; Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States., Nguyen MTH; Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States., Wen J; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hernandez Gonzalez SL; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Rodgers SP; Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States., Olmsted-Davis EA; Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States., Hamilton DJ; Department of Medicine, Center for Bioenergetics, Houston Methodist Research Institute, Houston, TX, United States., Reyes-Gibby C; Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Yeung SJ; Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Cooke JP; Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States., Herrmann J; Cardio Oncology Clinic, Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States., Chini EN; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, FL, United States., Xu X; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States., Yusuf SW; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Yoshimoto M; Center for Stem Cell & Regenerative Medicine, The University of Texas Health Science Center at Houston, Houston, TX, United States., Lorenzi PL; Department of Bioinformatics and Computational Biology, Division of VP Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hobbs B; Department of Population Health, The University of Texas at Austin, Austin, TX, United States., Krishnan S; Department of Neurosurgery, The University of Texas Health Science Center at Houston, Houston, TX, United States., Koutroumpakis E; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Palaskas NL; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wang G; Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States., Deswal A; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lin SH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Abe JI; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Le NT; Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States.

Publikováno v: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 Sep 14; Vol. 10, pp. 1212174. Date of Electronic Publication: 2023 Sep 14 (Print Publication: 2023).

Editorial: Case reports in cardio-oncology: 2022.

Autor: Ewer MS; MD Anderson Department of Cardiology, Internal Medicine Division, The University of Texas, Houston, TX, United States., Yusuf SW; MD Anderson Department of Cardiology, Internal Medicine Division, The University of Texas, Houston, TX, United States., Asmis R; Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States., Abe JI; MD Anderson Department of Cardiology, Internal Medicine Division, The University of Texas, Houston, TX, United States.

Publikováno v: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 Jul 13; Vol. 10, pp. 1235015. Date of Electronic Publication: 2023 Jul 13 (Print Publication: 2023).

Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis.

Autor: Koutroumpakis E; Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Niku A; Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Black CK; Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ali A; Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sadaf H; Department of Pathology and Laboratory Medicine, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX, United States., Song J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Palaskas N; Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Iliescu C; Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Durand JB; Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Yusuf SW; Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lee HC; Division of Cancer Medicine, Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Buja LM; Department of Pathology and Laboratory Medicine, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX, United States., Deswal A; Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Banchs J; Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, United States.

Publikováno v: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 Jan 24; Vol. 9, pp. 1073804. Date of Electronic Publication: 2023 Jan 24 (Print Publication: 2022).